✦ LIBER ✦

Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris

✍ Scribed by Annesofie Faurschou; Robert Gniadecki

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of refractory pemphigus vulgaris

✍ Lynne H. Morrison 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Anti-CD20 monoclonal antibody (rituximab

✍ M.J. Arin; A. Engert; T. Krieg; N. Hunzelmann 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Anti-CD20 chimeric monoclonal antibody (

✍ Thomas G. Salopeka; Sarvesh Logsettyb; Edward E. Tredgetb 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Rituximab: A monoclonal antibody to CD20

✍ Abdul Kader El Tal; Marshall R. Posner; Zachary Spigelman; A. Razzaque Ahmed 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Response of pemphigus vulgaris to anti-C

✍ A. S. Belgi; M. Azeez; C. Hoyle; R. E. A. Williams 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Successful Treatment of Refractory Child

✍ Heidi H. Kong; Neil S. Prose; Russell E. Ware; Russell P. Hall III 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB